Clinical characteristics and burden of COVID-19 in children and adolescents in Colombia: a retrospective database analysis
Authors:
Open Access
- 28 March 2025
- journal article
- infectious diseases
- Published by BMJ in BMJ Paediatrics Open
- Vol. 9 (1) , e003243
Abstract
Background: The burden of COVID-19 infections has been extensively studied in some parts of the world. However, in emerging economies and particularly in Latin America and Colombia, research is still incomplete, especially in the paediatric population. This study aims to investigate the burden of COVID-19 infections in children and adolescents in Colombia to understand the burden and outcomes of COVID-19. Methods: This is a retrospective database analysis of 0–17-year-old persons diagnosed with COVID-19 and given inpatient or outpatient care at a large health maintenance organisation covering 10% of the entire population from March 2020 to January 2023. Cases were confirmed by International Classification of Diseases 10th Revision codes for COVID-19 and a lab test. The incidence rates of COVID-19 cases per 100 000 persons were calculated. With a multivariate logistic regression model adjusted for demographical and clinical characteristics, the factors related to developing severe or critical COVID-19 during the study period were identified. Results: Of the 76 376 COVID-19 cases included in the analysis, the mean age was 9.8 years, about 51.5% were male, 99.6% lived in urban areas and 98.9% were unvaccinated (76.9% of the cases occurred before the vaccination of this group began on 31 October 2021). Most cases (69 528, 91%) were classified as mild, 0.9% as moderate, 8% as severe and 0.1% as critical. The most prominent comorbidities were mental health-related conditions (18.9%), chronic lung disease (13.6%) and immunocompromised condition (10.6%). 28 deaths were observed, of which 22 had at least 1 comorbidity, the most frequent being chronic lung disease and mental health conditions. Conclusion: Nearly 1 in 5 cases of COVID-19 was documented in children with underlying medical conditions. Our findings underscore the need to target children with comorbidities.Keywords
Funding Information
- Pfizer Colombia (N/A)
This publication has 31 references indexed in Scilit:
- Therapeutic interventions and the length of hospital stay for pediatric patients with COVID-19: a multicenter cohort studyScientific Reports, 2023
- COVID-19 Impact on Disparity in Childhood Immunization in Low- and Middle-Income Countries Through the Lens of Historical PandemicsCurrent Tropical Medicine Reports, 2022
- Characteristics and clinical outcomes of COVID-19 in children: a hospital-based surveillance study in Latin America's hardest-hit cityIJID Regions, 2022
- Epidemiological characterization of the pediatric population diagnosed for SARS-CoV-2 in the public health laboratory from Tolima, Colombia: A retrospective analysis 2020–2022Travel Medicine and Infectious Disease, 2022
- Effectiveness of COVID-19 vaccines in older adults in Colombia: a retrospective, population-based study of the ESPERANZA cohortThe Lancet Healthy Longevity, 2022
- Common seasonal respiratory viral infections in children before and during the coronavirus disease 2019 (COVID-19) pandemicInfection Control & Hospital Epidemiology, 2021
- Association of Children’s Physical Activity and Screen Time With Mental Health During the COVID-19 PandemicJAMA Network Open, 2021
- Association Between Income Inequality and County-Level COVID-19 Cases and Deaths in the USJAMA Network Open, 2021
- COVID-19 and income inequality in OECD countriesThe European Journal of Health Economics, 2021
- COVID-19 and obesity in childhood and adolescence: a clinical reviewJornal de Pediatria, 2020